RENIBUS THERAPEUTICS
Live / Registered — Registered (as of 04 Feb 2020)
What this means for you
Registered since 04 Feb 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87033391
- Registration number
- 5978434
- Mark type
- Stylized text
- Filed
- 11 May 2016
- Published for opposition
- 18 Oct 2016
- Registered
- 04 Feb 2020
- Attorney of record
- XAVIER MORALES
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of heart disease, kidney disease, liver disease, and acute kidney injury (AKI)
Owner
- Renibus Therapeutics, Inc., Argyle, TX, US
- Renibus Therapeutics, Inc., Argyle, TX, US
- Renibus Therapeutics, Inc., Lantana, TX, US
Prosecution history
- 04 Feb 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Oct 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Oct 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Oct 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Feb 2020 — REGISTERED-PRINCIPAL REGISTER
- 31 Dec 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Dec 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Dec 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 13 Dec 2019 — USE AMENDMENT FILED
- 13 Dec 2019 — TEAS STATEMENT OF USE RECEIVED
- 18 Jun 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jun 2019 — SOU EXTENSION 5 GRANTED
- 13 Jun 2019 — SOU EXTENSION 5 FILED
- 17 Jun 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 13 Jun 2019 — SOU TEAS EXTENSION RECEIVED